Dupont Capital Management Corp Moderna, Inc. Transaction History

Dupont Capital Management Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 28, 2023	SELL	$135.66 - $197.02 $300,486 - $436,399	-2,215 Reduced 96.85%	72 $11,000
Q4 2022 Jan 26, 2023	SELL	$118.38 - $210.04 $24,978 - $44,318	-211 Reduced 8.45%	2,287 $0
Q3 2022 Oct 31, 2022	SELL	$118.07 - $194.18 $51,360 - $84,468	-435 Reduced 14.83%	2,498 $295,000
Q2 2022 Jul 26, 2022	SELL	$117.13 - $176.59 $39,121 - $58,981	-334 Reduced 10.22%	2,933 $419,000
Q1 2022 Apr 27, 2022	SELL	$126.46 - $235.05 $190,828 - $354,690	-1,509 Reduced 31.6%	3,267 $563,000
Q4 2021 Jan 31, 2022	SELL	$225.82 - $368.51 $972,380 - $1.59 Million	-4,306 Reduced 47.41%	4,776 $1.21 Million
Q3 2021 Nov 03, 2021	BUY	$221.9 - $484.47 $758,454 - $1.66 Million	3,418 Added 60.35%	9,082 $3.5 Million
Q2 2021 Jul 30, 2021	BUY	$129.91 - $234.98 $735,810 - $1.33 Million	5,664 New	5,664 $1.33 Million
Q4 2020 Jan 28, 2021	SELL	$65.74 - $169.86 $293,068 - $757,235	-4,458 Closed	0 $0
Q3 2020 Oct 29, 2020	BUY	$54.34 - $94.85 $242,247 - $422,841	4,458 New	4,458 $315,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.